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INTRODUCTION
Eczema is the most common chronic 
inflammatory skin disease and, after skin 
infections, the most frequent reason for a 
new dermatological consultation in general 
practice.1 The majority of children with 
eczema have mild to moderate disease and 
are managed in primary care by GPs. It can 
place a heavy burden on the affected child 
and their family,2,3 and requires a high level 
of self-management.4 
There is a paucity of studies examining 
the management of patients with eczema 
in primary care. Evidence suggests 
that emollients are underused5,6 and, 
historically, the majority of children referred 
to dermatology outpatient clinics have 
mild-to-moderate disease which could be 
managed in primary care.7 The literature 
suggests that the most common reason 
for treatment failure is non-adherence to 
topical treatments.8 Reasons for this have 
been identified in qualitative studies with 
parents and carers (hereafter parents) and 
include: under appreciation by healthcare 
professionals of their child’s condition, 
confusion about eczema and its treatment 
regimens, and fears over medication side-
effects, especially topical corticosteroids 
(TCS).9–12 Patients’ perception of ‘dismissive’ 
and ‘unsympathetic’ attitudes by GPs 
have been reported,13 and a survey from 
the  National Eczema Society in 1993 found 
that patient expectations had only been 
completely met in 12% of GP consultations.14 
However, the perspective of GPs on the 
management of childhood eczema is not 
known.
As part of a wider study developing a 
written action plan (WAP) to support self-
management by parents and children,15 the 
authors sought to explore GPs’ experience 
and confidence in the diagnosis and 
management of children with eczema.
METHOD
Recruitment
GPs were recruited from practices 
participating in the authors’ eczema WAP 
study, professional networks, and by word 
of mouth.16 All responders completed an 
online screening questionnaire. Purposive 
sampling17 was used to recruit a range 
of participants by sex, years in role, and 
sociodemographic area of practice.
Interviews
GPs gave written informed consent to 
participate, and a reimbursement of £50 
was offered for their time. Semi-structured 
interviews were carried out in participants’ 
practices, homes, and by telephone between 
September 2016 and January 2017. An 
interview topic guide based on the aims 
of the study and the available research 




Eczema is common among children, and in 
the UK the majority are managed by GPs. The 
most common cause of poor disease control 
is incorrect use of topical treatments. There is 
a lack of research into the challenges faced by 
GPs in diagnosing and managing this condition.
Aim
To explore the experiences of GPs in assessing 
and managing children with eczema.
Design and setting
Qualitative study in primary care in England.
Method
Semi-structured interviews with 15 GPs were 
audiorecorded, transcribed verbatim, and 
analysed thematically using the framework 
method. 
Results
GPs described a paucity of dermatology training. 
Although most GPs were confident diagnosing 
uncomplicated eczema, they reported using 
a trial-and-error approach to prescribing 
emollients, and were uncertain about quantities 
of topical treatments to issue. Mild and 
moderate potency topical corticosteroids (TCS) 
were commonly used, but most GPs lacked 
confidence in recommending potent TCS, and 
viewed parents or carers to be fearful of using 
all strengths of TCS. GPs perceived adherence 
to treatments to be low, but provision of 
information to support self-care was variable. 
Routine review of medication use or disease 
control was uncommon, which GPs attributed 
to service constraints. Participants’ views on 
the causes and management of eczema were 
perceived to be at odds with parents and carers, 
who were said to be overly focused on an 
underlying cause, such as allergy.  
Conclusion
GP uncertainty in managing eczema, lack of 
routine information and review, and perceived 
dissonance with parents around causation 
and management may be contributing to low 
concordance with treatments. 
Keywords
atopic eczema/dermatitis; eczema; paediatrics; 
primary health care; qualitative research.
E Le Roux, MRCGP, Elizabeth Blackwell Institute 
clinical fellow; K Powell, MSc, research associate; 
MJ Ridd, PhD, FRCGP, GP, senior lecturer, Centre 
for Academic Primary Care, School of Social and 
Community Medicine, University of Bristol, Bristol. 
JP Banks, PhD, research fellow, National Institute 
for Health Research Collaborations for Leadership 
in Applied Health Research and Care West (NIHR 
CLAHRC West), University Hospitals Bristol NHS 
Foundation Trust, Bristol, UK.
Address for correspondence
Matthew Ridd, Centre for Academic Primary 
Care, Bristol Medical School, University of Bristol, 
Canynge Hall, 39 Whatley Road, Bristol BS8 2PS, 
UK.
Email: m.ridd@bristol.ac.uk
Submitted: 15 June 2017; Editor’s response: 31 
July 2017; final acceptance: 15 September 2017.
©British Journal of General Practice
This is the full-length article (published online 
16 Feb 2018) of an abridged version published in 
print. Cite this version as: Br J Gen Pract 2018; 
DOI: https://doi.org/10.3399/bjgp18X694529
Emma Le Roux, Kingsley Powell, Jonathan P Banks and Matthew J Ridd
GPs’ experiences of diagnosing and managing 
childhood eczema: 
a qualitative study in primary care
e73  British Journal of General Practice, February 2018
during the study as new issues arose (Box 1). 
Interviews lasted between 30 and 68 minutes, 
were audiorecorded, transcribed verbatim, 
checked, and anonymised. Reflexive field 
notes were made following the interviews.
Analysis
Transcripts were imported to NVivo 10 
software to facilitate coding and data 
organisation. Inductive thematic analysis, 
using a framework approach, was undertaken 
concurrently with data collection.18 A coding 
frame based on data from the first four 
GP transcripts was applied to subsequent 
transcripts and refined iteratively, applying 
the constant comparative method derived 
from grounded theory approaches.19 
The members of the research team met 
regularly to resolve coding queries, and a 
subset of interviews (n = 3) were analysed 
independently, with coding discrepancies 
discussed to maximise rigour and enable 
further refining of the coding framework. 
Codes were compared both within and 
across interviews, and then grouped into 
key themes and subthemes. Data collection 
was discontinued once the main themes 
were developed with no new information 
emerging (data saturation).20
RESULTS
Expressions of interest were received from 
48 GPs in 20 practices. Of the 32 GPs invited 
to interview, 15 (47%) took part; 13 interviews 
were undertaken face-to-face and two by 
telephone. 
The 11 female and four male participants 
had a range of personal characteristics and 
worked in a variety of practices located in 
Bristol, Gloucestershire, Portsmouth, and 
Nottingham, England (Table 1). Most GPs 
reported working in practices serving mainly 
white British patients, although several 
reported having communities of eastern 
European patients, particularly Polish. 
One-third of the GPs interviewed work 
within inner-city practices or had a branch 
surgery, where they reported seeing a higher 
proportion of ethnic minorities. 
Three main themes emerged: dermatology 
training, education, and practice; eczema 
consultations; and GPs’ perception of 
parental management of eczema.
Dermatology training, education, and 
practice 
Both recently qualified GPs and those with 
more experience felt that eczema was 
generally accorded a low priority in primary 
care practice, and this was also reflected 
in a lack of training at undergraduate and 
postgraduate level:
‘We did a very brief stint on dermatology and, 
um, I remember quite a few extreme cases. 
I’m not sure how much I learnt about the 
sort of dermatology that we see in general 
practice as an outpatient.’ (GP 14, female 
partner, 11 years’ experience)
Exceptions to this were two GPs with a 
specialist interest (GPSI) who had undertaken 
a diploma in dermatology, and one GP who 
had undertaken a dermatology position as 
part of a medical rotation before GP training. 
GPs maintained their dermatology 
knowledge through study days or peer 
group learning. Some relied on dermatology 
outpatient letters about their patients as a 
learning resource:
‘I tend to learn also what’s the appropriate 
strength [of TCS] by reading the 
dermatologist’s letter that comes back.’ 
(GP 5, female partner, 12 years’ experience) 
A minority of GPs said their practice 
How this fits in
In the UK, GPs diagnose and manage 
most children with eczema, but treatment 
failure is common due to low concordance 
with topical treatments. GPs in this study 
expressed uncertainties in prescribing 
emollients and topical corticosteroids, 
and proactive review of patients was 
uncommon. Reaching a shared treatment 
plan with carers may be hampered by 
differences between carer and professional 
views of the role of allergy in eczema 
causation. Clear treatment guidance by 
GPs, along with proactive review, may help 
address parents’ concerns and improve 
outcomes.
Box 1. Interview topic guide
•  Professional background, current role, years in role, clinical interests and responsibilities, undergraduate 
and vocational training in dermatology, access to GP with specialist interest in dermatology, practice 
demographics.
• What resources do you use to support you with diagnosing and managing eczema?
•  Can you describe your experience of looking after children with eczema, including recent case review? 
(Frequency of encounters, medications issued, difficulties encountered around diagnosis, treatment, or advice 
given).
• Have you managed any cases of infected eczema? (Advice and treatment offered).
• How often are you aware of parents or carers using complementary and alternative therapies?
• What is your approach to parent or carer questions around eczema and allergies?
• What follow-up arrangements do you usually make?
• How do you assess compliance with eczema treatments?
• When would you consider referring a child for specialist advice?
• How have you/do you try to support parents/carers in looking after their child?
• Are there any other tools/resources you think might be helpful to improve the care of children with eczema?
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had a GP dermatology lead to whom 
they would make internal referrals when 
uncertain about patient management. 
Rather than using guidelines, GPs turned to 
professional online resources (for example, 
www.gpnotebook.co.uk), links from within 
the clinical software systems, or Google 
searches for guidance. Websites with 
photographs were utilised to achieve a 
shared understanding with the parents of 
the working diagnosis:
‘Dermnet, it’s my favourite, and I quite like 
getting the pictures up and saying to patients 
“right, what do you think, you know, look at 
this, this looks like yours“, and patient.co.uk 
as well.’ (GP 8, female salaried, 14 years’ 
experience)
Some GPs viewed consultations for 
eczema as an opportunity to catch 
up if running late. These opinions were 
coupled with an overall feeling that, due 
to competing demands of chronic disease 
management and multimorbidity in an 
ageing population, dermatology is a low 
priority in general practice. The impact of 
childhood eczema and its effect on quality of 
life were infrequently described:
‘Dermatology is not really that important in 
primary care at the moment, I have to say 
[laughs]. There’s much more — there’s the 
care of the elderly and their management 
which is preoccupying all of us, getting 
people out of hospitals or not to get into 
hospitals.’ (GP 2, male partner, GPSI, 
16 years’ experience)
However, for those GPs with a specialist 
interest in dermatology, and those with 
personal experience of eczema, eczema 
consultations were described as time 
consuming:
‘The consultation tends to overrun with me 
because I feel like there’s a lot, you know, 
when you’re dealing with someone whose 
eczema’s not well-managed, there’s a lot to 
cover in 10 minutes.’ (GP 4, male salaried, 
child with eczema, <1 years’ experience)
Eczema consultations
Diagnosis. Diagnosing eczema in children 
was not reported to present a challenge 
to most GPs. Where uncertainty was 
described, it was in the context of a rash 
in an atypical distribution or where the 
differential diagnosis included a fungal 
or viral infection. There was also varying 
confidence in recognising bacterial and viral 
infection complicating eczema, and eczema 
in different ethnic skin types:
‘Sometimes, uh, [pause] it can be hard to 
know if they’ve got an infection or not, and 
sometimes you see them a couple of times 
and there’s nothing obvious. There’s [sic] no 
pustules or anything like that, and you give 
antibiotics a go ‘cos it’s a systemic, florid 
flare, and actually it all settles down.’ (GP 1, 
female partner, 13 years’ experience) 
‘Black African patients, yeah that can be 
difficult actually. I’ve not seen it a lot. I 
don’t know if it’s less common but, um, but 
yes, you know they’ll show you eczema and 
you’re thinking gosh, is it?’ (GP 13, female 
salaried, 17 years’ experience)
Treatment. Almost half of GPs interviewed 
said they routinely asked about current 
skin care regimens, and most expressed 
an awareness that parents have usually 
tried over-the-counter topical products, 
although use of complementary and 
alternative therapies was said to be 
uncommon. Though many GPs were aware 
of parents that disliked the consistency of 
some emollient treatments, few reported 
discussing options with parents, or sought 
agreement about what was acceptable 
to them before prescribing. With a large 
range of emollients available, a trial-and-
error approach to prescribing emollients 
was commonplace, with GPs also being 
uncertain about quantities to issue:
‘Regarding emollients, I guess the 
challenging thing about them is saying: “I 
don’t know which one is going to be the right 
one for you, and you may have to try 10 before 
you get one that suits you.” I wish I could 
make it easier for people [laughs], but it is 
Table 1. Characteristics of participants and their practices (n = 15)
Personal
Mean age, years (range) 44 (30–56)
Mean years in role (range) 14 (0.5–29)
GP partner 3 Male, 7 Female
Salaried GP 1 Male, 4 Female
Specialist interest in dermatology 1 Male, 1 Female
Personal experience of eczema (family member affected) 2 Male, 0 Female
Mean self-reported confidence with eczema management, 0 low, 10 high (range) 7.3 (5–9)
Practice
Mean list size (range) 10 441 (5478–18 221)
Mean practice IMD 2015,a  1 low, 10 high (range) 6.2 (1–10)
aIndex of multiple deprivation (IMD) 2015 (an overall measure of deprivation experienced by people living in an area).
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a bit of trial and error.’ (GP 4, male salaried, 
child with eczema, <1 years’ experience)
‘I think my knowledge on it’s a bit dodgy 
[laughs], ‘cos I can never remember how 
many — how many tubs you’re supposed to 
get through in a week if you’re using properly.’ 
(GP 7, male partner, 2 years’ experience)
Although several GPs found the 
formularies within clinical systems helped 
them with prescribing, others complained 
that systems which automatically 
recommended switches to more cost-
effective products created confusion for 
parents and clinicians, who were unfamiliar 
with the alternative products. Sometimes 
when changes were made, it brought GPs 
into conflict with parents wanting previously 
prescribed treatments:
‘Some patients have a particular cream that 
they want to be prescribed for them that’s 
not on the formulary or is more expensive, 
so that can provide a bit of conflict around 
whether you should or shouldn’t do that as to 
what the evidence is versus the cost versus 
patient choice.’ (GP 9, female partner, 11 
years’ experience)
All participants were confident prescribing 
mild and moderate potency TCS in 
children with eczema. However, there was 
widespread reluctance to prescribe a potent 
TCS in children when indicated, unless 
accompanied by a specialist dermatology 
referral: 
‘On the body, um, I’d go up to Eumovate™ 
[clobetasone butyrate], and if I was referring 
to dermatology I’d go up to Elocon® 
[mometasone furoate], but only in the 
context of doing a derm referral as well.’ (GP 
12, male partner, 4 years’ experience)
The fear of potent steroid use among GPs 
was evident in the experience of the GPSI 
below who took referrals from colleagues:
‘It’s always the stigma of steroid prescriptions 
which is not helped by my colleagues, which 
[sic] still have that unfortunate thing in their 
head that the steroids are very dangerous 
and only prescribe hydrocortisone even if the 
eczema is quite bad.’ (GP 2, male partner, 
GPSI, 16 years’ experience)
Advice given to parents about TCS 
risks, and using them sparingly, as well 
as a stepwise approach to potencies, was 
mentioned by most of the interviewees, 
although several participants expressed 
uncertainty about quantities of TCS to 
prescribe. GPs’ underconfidence with 
potent TCS is compounded for some by 
their perception of parental fear of TCS. 
Some reported a need to address parental 
misconceptions around TCS safety and the 
challenging conversations they experienced 
with parents around TCS use:
‘They worry about side-effects so they go 
“oh, does that mean that they’re going to 
get — the skin’s going to be thin, and they’re 
going to be prone to infection, and is that safe 
to use on a long-term basis?” and that sort 
of conversation.’ (GP 8, female salaried, 14 
years’ experience)
A minority of participants described 
managing some patients who they felt were 
over reliant on TCS:
‘So it’s trying to get them to understand 
that if they put in the hard graft and use 
the moisturiser more frequently, they can 
reduce their steroid use and reserve the 
steroid for when it’s really necessary.’ (GP 14, 
female partner, 11 years’ experience)
Supportive information offered and 
review. GPs tended to only give limited 
supportive information, with a minority 
reporting giving advice about avoidance of 
triggers and irritants, or instructions on the 
quantity or application of topical treatments. 
When written information was offered, the 
resources most commonly referred to were 
websites, with only a few GPs providing 
(informal) written instructions or viewing the 
prescription as a form of written advice. 
Several GPs expressed a desire to have 
greater access to community dermatology 
nurses, who they felt had more time and 
expertise to explain treatments:
‘It would be nice if we could refer directly 
to an eczema nurse or a nurse specialist. I 
think their wealth of knowledge in terms of 
practical use is awesome, and I think they’d 
be a lot better at the management plan and 
going through stuff with parents.’ (GP 12, 
male partner, 4 years’ experience)
Review of patients with eczema was a 
reactive process, in which around half of GPs 
said they routinely gave safety net advice; 
that is, to return if their eczema became 
infected or treatment escalation was needed. 
Proactive assessment of symptoms and 
adherence to treatments was uncommon, 
although many GPs saw their potential 
value. They attributed the current lack of 
routine review to pressure on appointments, 
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no financial incentives to undertake such 
reviews, and shortage of trained nurses to 
support them:
‘Well, in an ideal world you’d follow them up, 
but in the busy practice and demands on a 
patient appointment then I would follow-up if 
they felt they needed it. No formal follow-up, 
unless it was absolutely awful and you felt 
you had to see it.’ (GP 9, female partner, 11 
years’ experience)
GPs’ perception of parental management 
of eczema
GPs perceived differences to parents 
regarding the assessment of the severity 
of eczema, underlying aetiology, and 
expectations around treatments and/or 
referrals. GPs thought that parents struggled 
with their understanding of eczema as a 
long-term condition: 
‘I don’t think they find it difficult to accept 
that this is called eczema. I think it’s difficult 
accepting that it will be chronic and they will 
have a tendency to it, and accepting that 
it’s not caused by something that they can 
treat and then it will go away.’ (GP 6, female 
salaried, 23 years’ experience)
GPs felt online resources and word-of-
mouth were the most common sources 
of advice for parents of children with 
eczema, with the internet being blamed for 
misinformation around allergies:
‘There’s a lot of internet misinformation 
about allergy testing as well, I think.’ (GP 14, 
female partner, 11 years’ experience)
Most GPs believed that the evidence for 
food allergy causing eczema was weak, 
except when the clinical history strongly 
supported this, or in more severe cases of 
eczema. 
Uncertainty was expressed about how 
to discuss allergy testing and dietary 
manipulation with parents:
‘I also find it quite hard to understand myself 
so it is — I find it quite hard to explain to 
people in the context of eczema who might 
and who is unlikely to benefit from allergy 
testing, and realistically what they can hope 
to achieve.’ (GP 14, female partner, 11 years’ 
experience)
In addition, GPs were concerned about 
the limitations of currently available allergy 
tests, as well as a shortage of allergy clinic 
appointments and a desire to conserve 
resources:
‘Just because they react to it when you 
stick a needle under their skin with this 
particular substance doesn’t mean it’s 
necessarily what’s going to be triggering 
their eczema when they eat it, or any of 
their other allergies.’ (GP 1, female partner, 
13 years’ experience)
GPs tended to dissuade referral for 
allergy testing or trials of exclusion diets. 
Sometimes this was done by explaining their 
concerns about the limitations of testing, or 
by simply:
‘... telling them not to go down that route if 
they can.’ (GP 3, female salaried, 20 years’ 
experience)
A few GPs reported feeling pressured by 
parents to refer children for allergy testing:
‘Well, it’s difficult, because it depends on 
the patient, doesn’t it? ‘Cos some of them 
just want to see an allergist.’ (GP 13, female 
salaried, 17 years’ experience)
GPs reported that parents struggled to 
recall the names of previous treatments, 
making it a challenge for them to keep track 
of what had been tried. This, together with 
participants’ perception that parents have 
difficulty recalling instructions on their use, 
may be contributing to the confusion with 
treatments which GPs felt was common in 
eczema care:
‘Cos some of them are like, ‘oh I don’t know, 
uh well this tube, the red one, you know’. 
They don’t remember what the names of 
their medication — the creams are.’ (GP 3, 
female salaried, 20 years’ experience)
Records of repeat prescriptions on 
patients’ electronic medical records were 
the most commonly reported method used 
by GPs to assess adherence to treatments, 
particularly emollients. 
Underuse of both emollients and TCS by 
parents was felt to be common place:
‘When you question people about how 
they use steroids, they often use dribs and 
drabs for ever and ever, and not enough 




As far as the authors are aware, this is 
the first study to explore GPs’ experiences 
of diagnosing and managing children with 
eczema. Participants described important 
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gaps in training, knowledge, and practice. 
This was coupled with a feeling that other 
chronic diseases and older patients took 
priority. Apart from children with darker 
skin types or with possible skin infections, 
diagnosis of eczema was straightforward for 
most GPs, yet there was uncertainty about 
prescription quantities, use of potent TCS, 
and a trial-and-error approach to emollients. 
Parents were reported to frequently forget 
medication names and instructions on their 
use, and low adherence to medications was 
felt to be commonplace, with reluctance 
to use TCS. However, support offered to 
parents by means of verbal and written 
advice about treatments was limited, and 
few participants said they routinely arranged 
reviews to assess treatment acceptability, 
adherence, and disease control. A particular 
challenge for GPs was reconciling parents’ 
concerns about allergy and requests for 
allergy testing with their understanding that 
it had no role for the majority of children.
Strengths and limitations
This sample was diverse with respect to 
age, years working as a GP, and practice 
population served. The discussion of real-life 
cases ensured that the data were grounded 
in everyday clinical practice and the authors 
believe that they achieved saturation as no 
new themes were emerging in the later 
interviews. However, the predominance of 
females and GP partners, as well as the 
self-selection of doctors with professional 
(specialist interest) or personal interest in 
eczema, may mean the views of GPs less 
confident with managing eczema are under-
represented. There may also be differences 
between the ‘public’ accounts given in the 
interviews and participants’ actual clinical 
practice. GPs’ views of parents are just that, 
and may be inaccurate or unconsciously 
biased. However, this work still provides 
important insights into professional 
perceptions and attitudes to parents or 
carers of children with eczema, and much of 
it is supported by the existing literature.
Comparison with existing literature
These results are consistent with previous 
work which has identified limited training for 
GPs in dermatology at both undergraduate 
and postgraduate levels.21,22 
The perception among GPs in this study 
of a low emphasis on dermatology within 
primary care due to increasing demands 
of an ageing population with complex 
comorbidities concurs with a recent 
qualitative study where GPs reported 
a larger palliative and chronic disease 
workload.23
In terms of treating and managing eczema 
in primary care, these findings of a trial and 
error approach to emollients by GPs are 
similar to previous studies with parents,9 
and there may be hidden costs in terms of 
parent confusion, repeated consultations, 
and GP–parent conflict when clinical 
prescribing systems encourage switching 
to more ‘cost-effective’ products. Although 
TCS have been shown to have a low risk 
of causing adverse effects when used 
appropriately,24 TCS ‘phobia’ among parents 
of children has been widely reported,10,25,26 
mirroring GPs’ views in this study that 
parents are fearful of using them. However, 
the authors also found that GPs themselves 
lack confidence in using potent TCS (despite 
current British guidelines recommending 
their use short term on the trunk or limbs 
in children >12 months when their eczema 
has not improved with mild-to-moderate 
potency TCS and secondary infection has 
been excluded).27 The typical advice given 
by GPs to parents in this study to use TCS 
sparingly concurs with a previous survey of 
GPs,28 and may be inadvertently contributing 
to parental fear of their use.
The authors have recently published 
research that found a mismatch between 
GP and parent assessment of eczema 
severity,6 and the 2007 NICE guidelines27 
flagged up that healthcare professionals can 
underestimate the psychosocial impact of 
the condition. Participants’ perception that 
parents are seeking an underlying cause 
for their child’s eczema, and struggle to 
source reliable online information, concurs 
with previous surveys and qualitative studies 
with parents.9,29,30 GPs in this study expressed 
uncertainty about referral for allergy testing 
or trial of exclusion diets which reflects both 
the controversy around the role of allergy in 
eczema,31,32 the limitations of allergy testing 
currently available,33,34 and the poor evidence 
base for exclusion diets in patients with 
eczema.34,35 Despite the lack of evidence, 
dietary manipulation by parents is common, 
with up to 75% of parents trying dietary 
exclusions (49% unsupervised), and 41% 
dietary supplementation.36 Similar findings 
to those in this study, of a lack of parental 
understanding of disease pathogenesis 
and treatment regimens, have also been 
previously identified.37 The differing 
perspectives and beliefs held by clinicians 
and parents undermines a solid basis for 
establishing a shared understanding and 
treatment plan. 
Implications for research and practice
Although the participants in this study 
probably had an above-average interest 
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and knowledge about eczema, this study 
highlights that the common, impactful 
primary care condition of eczema is 
accorded low priority in the context of high 
competing demands, and GPs’ knowledge 
and confidence in managing it could be 
improved. Specifically, GPs need to be aware 
of and acknowledge the psychosocial impact 
of eczema,38 and both understand and 
communicate the safe use of TCS. Confident 
use of TCS by GPs should encourage parents 
to be more comfortable with their safety, 
thereby helping reduce ‘steroid phobia’. 
Issuing prescriptions with both TCS potency 
information and fingertip unit directions 
on use are simple changes that could aid 
patient understanding of dosing.39 National 
guidelines recommend proactive follow-up,27 
and financial rewards to incentivise GPs 
to do this should be considered. Reviews 
may improve adherence,40,41 and could 
also reduce previously reported parental 
perception of feeling dismissed by their 
healthcare provider.9
Future research could further explore the 
extent to which stated barriers to better 
care of children with eczema are a product 
of system factors (for example, lack of 
time, limited access to allergy services) or 
attitudinal factors (for example, low regard 
for impact of the condition on the child 
and their family). While there is uncertainty 
over the clinical and cost-effectiveness 
of interventions to improve the self-
management of people with eczema,4 WAPs 
and signposting to high quality information 
are advocated27,42 to improve understanding 
and adherence with treatments. Within the 
context of the authors’ wider study looking at 
developing an eczema action plan, the GPs 
were generally supportive of such a tool.15 
Action plans may be one way to help 
address the information gap between GP 
and parent. However, further research is 
needed to evaluate the acceptability and 
clinical- and cost-effectiveness of WAPs for 
children with eczema in daily clinical practice. 
Future research should also consider the 
role of the practice nurse, which could be 
extended to include the review and support 
of families with eczema, as happens with 
the related atopic long-term condition of 
asthma. Allergy testing and food avoidance 
is an area of controversy in eczema and 
has been identified as a key area requiring 
further research,43 which is needed to clarify 
when investigation is most likely to benefit 
affected children and their families.
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